fda tirzepatide shortage resolved october 2 2024 Announced Removal of from the Drug List Zepbound, Mounjaro shortages are resolved,

Meanwhile, as controversy continues over whether Hims & Hers' recent Super Bowl commercial for compounded weight loss meds complied with FDA rules, FuturHealth announced a partnership with Vailsure, an independent laboratory

For compounded tirzepatide from a vial Compounded tirzepatide requires more preparation

When tirzepatide is "compounded," it means that the pharmacy producing the medication differs from the one manufacturing the brand name drug

Monitor your body: If you accidentally injected frozen/thawed medication, watch for injection site reactions and tell your doctor

Most common GLP-1 side effects The most common side effects of Semaglutide (GLP-1) medications include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)

The standard escalation schedule starts at 2.5 mg weekly for four weeks